Novavax, Inc. (NVAX)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS6700024010
8.62 USD
-1.60% today Updated 13 Nov 2026 15:26
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Novavax, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:26. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
25 Feb 2027
in 104 days · 08:00 · estimate 0.54
Last results
-0.19 vs -0.35 estimated
05 Nov 2026 · Beat +45.1%
Beat the estimate
8 of 12
4 missed · 0 in line · 7 beats in a row
Average surprise
+106.8%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 08:00 | 0.54 | — | — | Upcoming |
| 05 Nov 2026 08:00 | -0.35 | -0.19 | +45.1% | Beat |
| 06 Aug 2026 08:00 | -0.38 | -0.32 | +16.6% | Beat |
| 06 May 2026 08:00 | -0.37 | -0.06 | +83.8% | Beat |
| 26 Feb 2026 08:00 | -0.55 | 0.11 | +120.2% | Beat |
| 06 Nov 2025 08:00 | -1.13 | -0.47 | +58.0% | Beat |
| 06 Aug 2025 07:00 | 0.06 | 0.62 | +1,000.3% | Beat |
| 08 May 2025 07:00 | 0.71 | 2.93 | +313.5% | Beat |
| 27 Feb 2025 07:00 | -0.51 | -0.52 | -1.2% | Miss |
| 12 Nov 2024 08:00 | -0.75 | -0.76 | -1.9% | Miss |
| 08 Aug 2024 08:00 | 1.70 | 0.99 | -41.8% | Miss |
| 10 May 2024 02:00 | -1.08 | -1.05 | +2.8% | Beat |
| 28 Feb 2024 08:00 | -0.35 | -1.44 | -313.4% | Miss |
| 09 Nov 2023 08:00 | -2.21 | -1.26 | +43.0% | Beat |
| 08 Aug 2023 08:00 | -1.16 | 0.58 | +149.8% | Beat |
| 09 May 2023 06:00 | -3.42 | -3.41 | +0.3% | In line |
| 28 Feb 2023 16:00 | -1.05 | -2.28 | -117.6% | Miss |
| 08 Nov 2022 16:00 | 1.59 | -2.15 | -235.0% | Miss |
| 08 Aug 2022 16:00 | 5.18 | -6.53 | -226.0% | Miss |
| 09 May 2022 16:00 | 2.65 | 2.56 | -3.5% | Miss |
| 28 Feb 2022 16:00 | -1.80 | -11.18 | -520.4% | Miss |
| 04 Nov 2021 16:00 | -3.55 | -4.31 | -21.5% | Miss |
| 05 Aug 2021 16:00 | -3.25 | -4.75 | -46.2% | Miss |
| 10 May 2021 16:00 | -3.60 | -3.05 | +15.3% | Beat |
| 01 Mar 2021 16:00 | -2.24 | -2.70 | -20.7% | Miss |
| 09 Nov 2020 16:00 | 1.73 | -3.21 | -285.4% | Miss |
| 10 Aug 2020 16:00 | -0.33 | -0.30 | +9.8% | Beat |
| 11 May 2020 16:00 | -0.67 | -0.58 | +13.9% | Beat |
| 11 Mar 2020 16:00 | -1.05 | -1.13 | -7.9% | Miss |
| 07 Nov 2019 16:00 | -0.89 | -1.11 | -24.5% | Miss |
| 07 Aug 2019 16:00 | -1.59 | -1.69 | -6.4% | Miss |
| 02 May 2019 16:00 | -2.26 | -2.20 | +2.6% | Beat |
| 18 Mar 2019 16:00 | -2.39 | -2.60 | -8.6% | Miss |
| 07 Nov 2018 16:00 | -2.52 | -2.40 | +4.8% | Beat |
| 08 Aug 2018 16:00 | -2.46 | -2.40 | +2.6% | Beat |
| 09 May 2018 16:00 | -2.78 | -2.80 | -0.8% | In line |
| 14 Mar 2018 16:00 | -3.11 | -3.20 | -2.8% | Miss |
| 07 Nov 2017 16:00 | -3.19 | -3.00 | +5.9% | Beat |
| 08 Aug 2017 16:00 | -3.17 | -3.20 | -1.0% | In line |
| 08 May 2017 16:00 | -3.47 | -3.20 | +7.8% | Beat |
| 27 Feb 2017 16:00 | -4.56 | -4.20 | +7.9% | Beat |
| 09 Nov 2016 16:00 | -5.24 | -4.80 | +8.3% | Beat |
| 09 Aug 2016 16:00 | -5.08 | -5.80 | -14.2% | Miss |
| 04 May 2016 16:00 | -5.41 | -5.80 | -7.3% | Miss |
| 29 Feb 2016 07:00 | -2.95 | -5.80 | -96.4% | Miss |
| 09 Nov 2015 06:00 | -1.90 | -2.40 | -26.3% | Miss |
| 10 Aug 2015 16:00 | -1.81 | -1.60 | +11.5% | Beat |
| 07 May 2015 16:00 | -2.20 | -2.00 | +9.1% | Beat |
| 26 Feb 2015 16:00 | -1.80 | -2.60 | -44.4% | Miss |
| 05 Nov 2014 16:00 | -1.60 | -1.60 | 0.0% | In line |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 1.1B | +64.7% | 440.3M | 39.2% | 2.58 | +309.8% | -251M |
| 2024 | 682.2M | +22.6% | -187.5M | -27.5% | -1.23 | +77.3% | -101.9M |
| 2023 | 556.4M | -65.2% | -545.1M | -98.0% | -5.41 | +35.7% | -772.8M |
| 2022 | 1.6B | — | -657.9M | -41.1% | -8.42 | — | -508.9M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 10.83 | 11.20 | 8.56 | 8.61 | -20.13% | 34,572,074 | |
| 02 Nov 2026 – 06 Nov 2026 | 10.11 | 10.93 | 9.39 | 10.78 | +6.94% | 28,082,800 | |
| 26 Oct 2026 – 30 Oct 2026 | 9.56 | 10.65 | 8.95 | 10.08 | +3.92% | 23,310,100 | |
| 19 Oct 2026 – 23 Oct 2026 | 11.20 | 11.99 | 9.56 | 9.70 | -13.85% | 34,840,100 | |
| 12 Oct 2026 – 16 Oct 2026 | 12.61 | 13.34 | 11.11 | 11.26 | -11.69% | 42,701,800 | |
| 05 Oct 2026 – 09 Oct 2026 | 10.47 | 13.39 | 10.28 | 12.75 | +21.89% | 81,730,800 | |
| 28 Sep 2026 – 02 Oct 2026 | 10.50 | 11.11 | 10.26 | 10.46 | -1.60% | 20,259,700 | |
| 21 Sep 2026 – 25 Sep 2026 | 10.38 | 11.09 | 10.15 | 10.63 | +5.14% | 27,740,500 | |
| 14 Sep 2026 – 18 Sep 2026 | 9.38 | 10.38 | 9.14 | 10.11 | +7.32% | 29,557,400 | |
| 08 Sep 2026 – 11 Sep 2026 | 10.10 | 10.36 | 9.11 | 9.42 | -7.83% | 20,669,800 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Novavax to Participate in Jefferies London Healthcare Conference (opens in a new tab) 11 Nov 2026 22:00
- NVAX Q3 2026 deep dive: Sanofi milestone and cost controls shape outlook (opens in a new tab) StockStory · 10 Nov 2026 13:01
- Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It (opens in a new tab) Zacks · 10 Nov 2026 13:00
- Novavax (NVAX) stock trades up, here is why (opens in a new tab) StockStory · 10 Nov 2026 06:45
- Novavax, Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 10 Nov 2026 00:07
- Novavax (NVAX) Looks Cheap After Sanofi Milestone And Stronger Q3 Results (opens in a new tab) Simply Wall St. · 07 Nov 2026 16:10
- NVAX Stock Falls 8% Despite Q3 Earnings & Sales Beat, Costs Decline (opens in a new tab) Zacks · 06 Nov 2026 13:58
- B. Riley Securities Reiterates Buy on Novavax, Lowers Price Target to $16 (opens in a new tab) Benzinga · 06 Nov 2026 11:53
- Novavax Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 06 Nov 2026 10:14
- Novavax Inc (NVAX) (Q3 2026) Earnings Call Highlights: Sanofi Milestone Lifts Revenue Outlook ... (opens in a new tab) GuruFocus.com · 06 Nov 2026 01:15
- Novavax (NVAX) reports earnings tomorrow: what to expect (opens in a new tab) StockStory · 05 Nov 2026 23:41
- Novavax (NVAX) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 20:09
- Novavax Raises FY26 Revenue Outlook By 50% – Retail Says Licensing Deals Could Create ‘Tremendous Financial Leverage’ (opens in a new tab) Stocktwits · 05 Nov 2026 15:38
- Novavax (NASDAQ:NVAX) Q3 2026 Revenue Beats Estimates but Shares Slip on Sales Decline (opens in a new tab) ChartMill · 05 Nov 2026 14:39
- Novavax’s (NASDAQ:NVAX) Q3 2026: strong sales, guides for strong full-year sales (opens in a new tab) StockStory · 05 Nov 2026 14:07
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 8.76 USD
- Market cap
- 1.4B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow NVAX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.